Financials (USD)
Sales 2024 * | 101M | Sales 2025 * | 113M | Capitalization | 165M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | -12M | EV / Sales 2024 * | 1.63 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.47 x |
P/E ratio 2024 * |
-11.4
x | P/E ratio 2025 * |
-16.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.15% |
Latest transcript on OptimizeRx Corporation
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
1st Jan change | Capi. | |
---|---|---|
+13.22% | 381B | |
+13.91% | 239B | |
+12.04% | 144B | |
+15.04% | 99.5B | |
+14.99% | 79.04B | |
+28.70% | 51.42B | |
-2.38% | 34.84B | |
+9.71% | 31.04B | |
-11.64% | 22.34B |